Advanced wound care MedTech company recently reported a record second-quarter with $116.4M in revenue for H1, 2024 POMPANO BEACH, Fla., Aug. 29, 2024 (GLOBE NEWSWIRE) — BioStem Technologies, Inc. (OTC:…
POMPANO BEACH, Fla., Nov. 08, 2023 — BioStem Technologies Inc. (OTC:BSEM), a leading regenerative medicine company focused on the development, manufacture and commercialization of placental-derived biologics for advanced wound care, today…
POMPANO BEACH, Fla., May 29, 2024 (GLOBE NEWSWIRE) — BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental-derived biologics, will…
– Company Achieves Record-Breaking First Quarter Results for 2024, Marking the Launch of BioStem 2.0 –– Company Reports First Quarter EBITDA of $4.9 Million –– Project Continued Growth from Sales…
